Virtual Library

Start Your Search

  • WCLC 2019

    2019 World Conference on Lung Cancer

    Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain

    Presentation Date(s):  
    • Sept 7 - 10, 2019
    • Total Presentations: 2848

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.13 - Staging

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Staging
    • Presentations: 3
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.13-01 - The Importance of Staging of Lung Cancers, 30 mm or Less, Separately for Subsolid and Solid Nodules

      09:45 - 09:45  |  Author(s): Yong Wang

      • Abstract

      Loading...

    • +

      P1.13-02 - Should Aortic Lymph Nodes be Considered Hilar Lymph Nodes in Patients with Completely Resected NSCLC? A Multicenter Study

      09:45 - 09:45  |  Presenter: Necati Citak

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-03 - Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype

      09:45 - 09:45  |  Author(s): Ting Ye

      • Abstract

      Loading...

    • +

      P1.13-04 - Impact of the Presence and Proportion of GGO on Survival and Pathological Characteristics in Clinical Stage I Lung Adenocarcinoma (Now Available)

      09:45 - 09:45  |  Presenter: Shinya Katsumata

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-05 - Evaluation of PET/CT Scans to Predict Pathologic Lung Cancer Staging  (Now Available)

      09:45 - 09:45  |  Presenter: Mukunthan Murthi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-06 - Impact of Lymph Node Involvement and Tumor Location on Survival Following Resection for pN1/pN2 Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Author(s): Thomas Tsitsias

      • Abstract

      Loading...

    • +

      P1.13-07 - Comparison of the 7th and 8th Edition of TNM Staging for NSCLC in Patients Undergoing Pulmonary Resection After Neoadjuvant/Induction Treatment

      09:45 - 09:45  |  Presenter: Hüseyin Melek

      • Abstract

      Loading...

    • +

      P1.13-08 - The Maximum Standardized Uptake Values on Positron Emission Tomography Predict Pathological Characteristics of Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Terumoto Koike

      • Abstract

      Loading...

    • +

      P1.13-09 - Utility of Artificial Intelligence in Estimation of the Histologic Type of Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Yohei Kawaguchi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-10 - Incidence of Hidden Extrathoracic Metastases and Unexpected Second Malignancies Detected by PET in Patients with Lung Cancer

      09:45 - 09:45  |  Presenter: Bruno García Cabo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-11 - An Audit on IASLC Compliance of Lymph Nodes Dissection and Impact on Survival After Surgery for Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Author(s): Paulo De Sousa

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-12 - The Invasion of Mediastinal Fat Tissue Should be Considered for T4 Description in the Next TNM Classification of NSCLC

      09:45 - 09:45  |  Presenter: Necati Citak

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-13 - High-Risk Clinical Stage I Non-Small Cell Lung Cancer Based on High-Resolution Computed Tomography Findings  

      09:45 - 09:45  |  Presenter: Yasuhiro Tsutani

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.13-14 - Prognosis and Clinicopathologic Characteristics of Skip N2 Metastasis in Completely Resected Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Takaaki Tsuboi

      • Abstract

      Loading...

  • +

    P1.14 - Targeted Therapy

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Targeted Therapy
    • Presentations: 15
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.14-01 - Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC? 

      09:45 - 09:45  |  Presenter: Omer Fatih Olmez

      • Abstract

      Loading...

    • +

      P1.14-02 - Survey of EGFR Molecular Testing of NSCLC in the Asia-Pacific Region

      09:45 - 09:45  |  Presenter: Chong Kin Liam

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-03 - Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial

      09:45 - 09:45  |  Presenter: Lorenza Landi

      • Abstract

      Loading...

    • +

      P1.14-04 - Final Results of the Prospective Genomics of Young Lung Cancer (GYLC), an Addario Lung Cancer Medical Institute Study

      09:45 - 09:45  |  Presenter: Barbara Gitlitz

      • Abstract

      Loading...

    • +

      P1.14-05 - TP53 Exon 8 Mutation and Prognosis in EGFR-Mutated NSCLC Patients Treated with First-And-Second-Generation TKIs

      09:45 - 09:45  |  Author(s): Matteo Canale

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-06 - Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers

      09:45 - 09:45  |  Presenter: Adam J Schoenfeld

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-07 - Genomic Profiling of Liquid Biopsies During 2nd/3rd Generation ALK Inhibitor Therapy to Identify Novel Mechanisms of Resistance

      09:45 - 09:45  |  Presenter: Erin L Stewart

      • Abstract

      Loading...

    • +

      P1.14-08 - Activity of Poziotinib and Other 2nd-Gen Quinazoline EGFR TKIs in Atypical Exon18 and Acquired Osimertinib Resistance Mutants

      09:45 - 09:45  |  Presenter: Jacqulyne Ponville Robichaux

      • Abstract

      Loading...

    • +

      P1.14-09 - Unveiling Hidden MET-Mediated Primary Alectinib Resistance in ALK-Positive Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Anh Tuan Le

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-10 - The Landscape of RET Genomic Alterations in Chinese Non-Small Cell Lung Cancer Patients

      09:45 - 09:45  |  Author(s): Xiangyan Liu

      • Abstract

      Loading...

    • +

      P1.14-11 - A Prospective Multicenter Study of Target-Capture Deep Sequencing in Paired Tissue and ctDNA to Guide EGFR-Mutated Lung Cancer Treatment (Now Available)

      09:45 - 09:45  |  Presenter: Shun Lu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-12 - A Novel Activating MAP2K1 In-Frame Deletion Mediates Acquired Resistance to ROS1 TKIs in a Patient with ROS1 Fusion-Positive NSCLC

      09:45 - 09:45  |  Presenter: Hiroki Sato

      • Abstract

      Loading...

    • +

      P1.14-13 - EGFR Amplification Mediates Resistance to Third-Generation EGFR TKIs and in Vitro Validation of Combination Strategies to Overcome Resistance (Now Available)

      09:45 - 09:45  |  Presenter: Yi-Chen Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-14 - Monitoring of EGFR Mutations During Osimertinib Treatment in Advance EGFR-Mutant T790M Positive NSCLC (Now Available)

      09:45 - 09:45  |  Presenter: Katja Mohorcic

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-15 - Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

      09:45 - 09:45  |  Author(s): Saadettin Kilickap

      • Abstract

      Loading...

    • +

      P1.14-16 - Resolving Resistance to Osimertinib by Combining Apatinib and Osimertinib in EGFR-Mutant NSCLC Patients

      09:45 - 09:45  |  Presenter: Xue Yang

      • Abstract

      Loading...

    • +

      P1.14-17 - Genomic Evolution During TKI Treatment in Non-Small Cell Lung Cancer Patients With or Without Acquired T790M Mutation

      09:45 - 09:45  |  Author(s): Ying Jin

      • Abstract

      Loading...

    • +

      P1.14-18 - ALK Inhibitor Sequencing and Outcomes Among ALK-Positive (ALK+) NSCLC Patients in the US Community Oncology Setting

      09:45 - 09:45  |  Author(s): David M Waterhouse

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-19 - Exome Analysis of Patients Treated with Afatinib Reveals Genetic Variations Discriminating Extreme Responders (Now Available)

      09:45 - 09:45  |  Presenter: Julie Niogret

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-20 - Tarloxotinib as a Novel Therapeutic Strategy for Oncogenic Alterations Across the ErbB Family of Receptors

      09:45 - 09:45  |  Presenter: Adriana Estrada-Bernal

      • Abstract

      Loading...

    • +

      P1.14-21 - Propensity-Matched Genomic Profiling Comparison of Lung Adenocarcinomas Among 3 Races, a Multicenter Study of 4655 Patients

      09:45 - 09:45  |  Presenter: Ke Lan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-22 - SASH1, a Novel Prognostic and Predictive Factor for PARP Inhibitors in Lung Cancer

      09:45 - 09:45  |  Presenter: Joshua Burgess

      • Abstract

      Loading...

    • +

      P1.14-23 - Resistance Mechanisms to Osimertinib Treatment in EGFR-Mutated Lung Cancer in a Real Life Cohort (Now Available)

      09:45 - 09:45  |  Presenter: Christi M.J. Steendam

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-24 - Characterization of Acquired Receptor Tyrosine Kinase Fusions as Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors (Now Available)

      09:45 - 09:45  |  Presenter: Haiyuan Xu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-25 - Targeting NRG1-Fusions in Lung Adenocarcinoma: Afatinib as a Novel Potential Treatment Strategy

      09:45 - 09:45  |  Presenter: Michael Duruisseaux

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-26 - ALK Fusion Variant Detection by Targeted RNA-Seq in TKIs Treated ALK-Positive Lung Adenocarcinoma

      09:45 - 09:45  |  Presenter: Fabrizio Tabbò

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-27 - Duration of Targeted Therapy in Advanced NSCLC (aNSCLC) with Drivers Identified by Circulating Tumor DNA (ctDNA) Analysis

      09:45 - 09:45  |  Presenter: Christina Baik

      • Abstract

      Loading...

    • +

      P1.14-28 - Correlation Between the Qualification for the Bevacizumab Use and the Survival of NSCLC Patients with EGFR Mutations

      09:45 - 09:45  |  Presenter: Taiki Hakozaki

      • Abstract

      Loading...

    • +

      P1.14-29 - Disrupting the Paradigm: Partnering with Oncogene-Focused Patient Groups to Propel Research

      09:45 - 09:45  |  Presenter: Janet Freeman-Daily

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-30 - Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

      09:45 - 09:45  |  Presenter: Takaaki Tokito

      • Abstract

      Loading...

    • +

      P1.14-31 - Lack of Association Between BIM Deletion Polymorphism and Clinical Efficacy of EGFR-TKIs in NSCLC Based on NGS (Now Available)

      09:45 - 09:45  |  Presenter: Si-Yang Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-32 - Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer Patients Treated with Ensartinib

      09:45 - 09:45  |  Presenter: Heather A Wakelee

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-33 - Canagliflozin Inhibits Lung Cancer Survival and Enhances Its Response to Radiotherapy; Effective Blockade of mTOR Pathway, HIF1a, and Mitosis

      09:45 - 09:45  |  Presenter: Evangelia Evelyn Tsakiridis

      • Abstract

      Loading...

    • +

      P1.14-34 - The Landscape of MET Alterations in Chinese Non-Small Cell Lung Cancer Patients

      09:45 - 09:45  |  Author(s): Min Zheng

      • Abstract

      Loading...

    • +

      P1.14-35 - Epithelial-To-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status

      09:45 - 09:45  |  Presenter: Koji Fukuda

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-36 - Phase II Trial of Afatinib in Elderly Patients Aged Over 75 Years with EGFR Mutation Positive Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Ryo Ko

      • Abstract

      Loading...

    • +

      P1.14-37 - Lung Cancer in Never-Smokers: A Nationwide Population Based Mapping of Targetable Alterations

      09:45 - 09:45  |  Author(s): Annette Salomonsson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-38 - Identification of FGFR1-3 Fusions in Lung Cancers Using Comprehensive Next-Generation Sequencing (Now Available)

      09:45 - 09:45  |  Presenter: Gen Lin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-39 - Acquired ALK Rearrangement in EGFR-Mutant Lung Adenocarcinoma Treated with EGFR TKIs

      09:45 - 09:45  |  Presenter: Qian-Yu Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-40 - EGFR-TKIs May Sensitize Radiation Lung Damage in Stereotactic Body Radiotherapy Based on Intensity Analyzing

      09:45 - 09:45  |  Presenter: Xingni Tang

      • Abstract

      Loading...

    • +

      P1.14-41 - The Combination of the PARP Inhibitor Olaparib and the ATR Inhibitor VE-821 Selectively Targets ATM-Deficient Lung Cancer Cells

      09:45 - 09:45  |  Presenter: Nicholas Jette

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-42 - Apatinib Combined with EGFR - TKI in Treating Advanced Non-Small Cell Lung Cancer with EGFR - TKI Resistance (Data Updated)

      09:45 - 09:45  |  Presenter: Ruifen Tian

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-43 - A Novel Patient Derived Synchronous Cell Pair with Different Mutations in an ALK-Rearranged Lung Adenocarcinoma Underlines Tumor Heterogeneity

      09:45 - 09:45  |  Presenter: Paul Stockhammer

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-44 - Positive PD-L1 Expression Is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with EGFR-TKIs

      09:45 - 09:45  |  Author(s): Seung Hyeun Lee

      • Abstract

      Loading...

    • +

      P1.14-45 - Surgical Outcome of Non-Small Cell Lung Cancer with Clinical Single Zone N2 in Aortopulmonary Zone (LN#5 and LN#6) (Now Available)

      09:45 - 09:45  |  Presenter: Kanghoon Lee

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-46 - Genomic Profiling of Large Cell Neuroendocrine Carcinomas of Lung:  A Path Towards Individualized Treatment Options

      09:45 - 09:45  |  Presenter: Nhu Thi Ngo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-47 - ctDNA NGS for Guiding Crizotinib Treatment in ALK-Rearranged Advanced NSCLC Patients (Pts) (Now Available)

      09:45 - 09:45  |  Presenter: Yong He

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-48 - Whole Exome Sequencing (WES) in Non-Small Cell Lung Carcinoma (NSCLC): Identification of Novel Biomarkers (Now Available)

      09:45 - 09:45  |  Presenter: Varsha Singh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-49 - The Role of ctDNA Detection (Liquid Biopsy) in Patients with NSСLC

      09:45 - 09:45  |  Presenter: Albina Zhabina

      • Abstract

      Loading...

    • +

      P1.14-50 - A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma (Now Available)

      09:45 - 09:45  |  Presenter: Robin Guo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-51 - LOC440416 lncRNA-Mediated Cell Cycle Arrest Regulated Crizotinib-Induced Hepatotoxicity

      09:45 - 09:45  |  Presenter: Xueqin Chen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-52 - Clinical Response to Osimertinib in a Patient with Metastatic NSCLC Harboring EGFR A763_Y764insFQEA Exon 20 Insertion Mutation: A Case Report (Now Available)

      09:45 - 09:45  |  Presenter: Gabriela Liliana Bravo Montenegro

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-53 - Co-Occurring CDKN2A/2B Alteration Is Associated with Poorer Survival in ALK-Positive Lung Cancer

      09:45 - 09:45  |  Presenter: Joo Young Ha

      • Abstract

      Loading...

    • +

      P1.14-54 - Previous Therapy Strategy Impact on Efficiency of Anlotinib Hydrochloride as 3rd Line Treatment: A Subgroup Analysis of ALTER0303 Trial (Now Available)

      09:45 - 09:45  |  Presenter: Sen Yang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-55 - Cost-Effectiveness of Ceritinib and Alectinib vs Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced NSCLC

      09:45 - 09:45  |  Presenter: Bin Wu

      • Abstract

      Loading...

    • +

      P1.14-56 - The Dynamic Range of Mutant Allele Fraction Detected in ctDNA from Patients with NSCLC: Clinical Experience Data and Clinical Implications

      09:45 - 09:45  |  Author(s): Smitha Boorgula

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-57 - Post-Ensartinib Outcomes in Refractory Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

      09:45 - 09:45  |  Author(s): Hans Kim

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-58 - A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Author(s): Julia Rotow

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-59 - Clinical Implications of the Pharmacokinetics of Dacomitinib Co-Administration with H2-Receptor Antagonists in Cancer Patients

      09:45 - 09:45  |  Presenter: Swan Lin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.14-60 - Statins Overcome Resistance to Tyrosine Kinase Inhibitors in Patient-Derived, Oncogene-Driven NSCLC Models

      09:45 - 09:45  |  Presenter: Weijie Ma

      • Abstract

      Loading...

    • +

      P1.14-61 - EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions

      09:45 - 09:45  |  Author(s): Andrés Felipe Cardona

      • Abstract

      Loading...

    • +

      P1.14-62 - Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Combined Analysis of Two Single-Arm Phase IIIb Studies

      09:45 - 09:45  |  Author(s): Filippo De Marinis

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.15 - Thymoma/Other Thoracic Malignancies

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Thymoma/Other Thoracic Malignancies
    • Presentations: 8
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.15-01 - Prognostic Factors and Long-Term Outcomes After Pulmonary Metastasectomy from Renal Cell Carcinoma (Now Available)

      09:45 - 09:45  |  Presenter: Domenico Galetta

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-02 - Role of mTOR Inhibitor Everolimus in the Treatment of Metastatic Thymic Epithelial Tumors

      09:45 - 09:45  |  Presenter: Jessica Hellyer

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-03 - Cabozantinib and R428 Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)

      09:45 - 09:45  |  Presenter: Pei-Wen Yang

      • Abstract

      Loading...

    • +

      P1.15-04 - Multimodality Treatment of Chest Wall Tumors: Induction Therapy Reduces Recurrence Rates (Now Available)

      09:45 - 09:45  |  Presenter: Milos Sarvan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-05 - Genomic Variation Landscape of Thymoma and Thymic Carcinoma in Chinese Patients (Now Available)

      09:45 - 09:45  |  Presenter: Naixin 13701089919 Liang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-06 - Resection of Thoracic Paragangliomas: A Multicenter Experience (Now Available)

      09:45 - 09:45  |  Author(s): Sergio Ibarra

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-07 - Combined Aortic Arch Resection for Thymic Cancer Using Total Rerouting of Supra-Arch Vessels

      09:45 - 09:45  |  Presenter: Yasushi Shintani

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-08 - Outcomes of T4 Esophageal Cancer Treated with Neoadjuvant Chemoradiation Followed by Surgery and Definitive Chemoradiation: A Meta-Analysis

      09:45 - 09:45  |  Presenter: Chia Ching Lee

      • Abstract

      Loading...

    • +

      P1.15-09 - The Impact of Minimal Invasive Esophagectomy and Neoadjuvant Chemoradiotherapy for Esophageal Malignancy: A Nationwide Database Analysis

      09:45 - 09:45  |  Presenter: Cheng-Hung How

      • Abstract

      Loading...

    • +

      P1.15-10 - Trabectedin Has Limited Clinical Activity in Pretreated Patients with Pleural Mesothelioma  (Now Available)

      09:45 - 09:45  |  Author(s): Giulia Pasquini

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-11 - Intrathoracic Neurogenic Tumors: Clinical, Pathological, and Long-Term Outcomes (Now Available)

      09:45 - 09:45  |  Presenter: Domenico Galetta

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-12 - A Different Aspect to Tumor Size Dilemma in Thymoma's TNM Staging Classification (Now Available)

      09:45 - 09:45  |  Author(s): Ayten Kayi Cangir

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.15-13 - Subxiphoid Uniportal Thoracoscopic Thymectomy Without Carbon Dioxide Insufflation in the Patients with Thymoma (Now Available)

      09:45 - 09:45  |  Presenter: Do Kyun Kang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Treatment in the Real World - Support, Survivorship, Systems Research
    • Presentations: 17
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.16-01 - Complications Associated with Lung Biopsies in Patients with Lung Cancer: A Population Based Analysis

      09:45 - 09:45  |  Author(s): Mitchell Von Itzstein

      • Abstract

      Loading...

    • +

      P1.16-02 - The Real-World Risk of Brain Metastases in Stage 3 Lung Cancer Patients in the Era of PET and MRI Staging (Now Available)

      09:45 - 09:45  |  Author(s): Ryan Brendan Ko

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-03 - Incidence and Risk Factors of Metachronous Non-Pulmonary Malignancies in Resected Lung Adenocarcinoma

      09:45 - 09:45  |  Presenter: Peter J Kneuertz

      • Abstract

      Loading...

    • +

      P1.16-04 - Real World Experience of Using Comprehensive Genomic Profiling of Plasma Circulating Tumor DNA

      09:45 - 09:45  |  Presenter: Yan Yan

      • Abstract

      Loading...

    • +

      P1.16-05 - Incidence and Outcome of Multiple Primary Cancers (MPC) in a Series of Lung Cancer (LC) Patients

      09:45 - 09:45  |  Presenter: Susana Cedres

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-06 - Early Changes in Pulmonary Function Are Associated with Development of Pneumonitis in NSCLC Patients Receiving Immune Checkpoint Blockade

      09:45 - 09:45  |  Presenter: Joshua Reuss

      • Abstract

      Loading...

    • +

      P1.16-07 - Real World Evidence of the Impact of Immunotherapy in Patients with Advanced Lung Cancer (Now Available)

      09:45 - 09:45  |  Author(s): Christopher Pettengell

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-08 - Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations

      09:45 - 09:45  |  Presenter: Sophia Valesca Gorgens

      • Abstract

      Loading...

    • +

      P1.16-09 - Post-Progression Outcomes After Pembrolizumab in Patients with NSCLC and High PD-L1 Expression: Real-World Data from a European Cohort

      09:45 - 09:45  |  Author(s): Giulio Metro

      • Abstract

      Loading...

    • +

      P1.16-10 - Real-World Efficacy of First-Line Pembrolizumab in Patients with Advanced PD-L1 High Non-Small Cell Lung Cancer in Argentina (Now Available)

      09:45 - 09:45  |  Author(s): Alejandro Daniel Kuzminin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-11 - A Dyad-Based Mindfulness Cancer Recovery Program for Survivors and Family Members to Reduce Lung Cancer Symptoms     (Now Available)

      09:45 - 09:45  |  Presenter: Karen Kane McDonnell

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-12 - An Analysis of Healthcare Use and the Cost Associated to End-of-Life Care of Lung Cancer Patients in a Spanish Hospital (Now Available)

      09:45 - 09:45  |  Author(s): Juan Luis Cruz

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-13 - Development of a Veterans Affairs Based Comprehensive Lung Cancer Survivorship Program

      09:45 - 09:45  |  Presenter: Scott Shofer

      • Abstract

      Loading...

    • +

      P1.16-14 - Effects of an Artificial Intelligence (AI) System on Clinical Trial Enrollment in Lung Cancer

      09:45 - 09:45  |  Presenter: Konstantinos Leventakos

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-15 - Rates of Systemic Anticancer Therapy (SACT) for Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US, 2011–2018

      09:45 - 09:45  |  Presenter: Vamsidhar Velcheti

      • Abstract

      Loading...

    • +

      P1.16-16 - Lung Cancer Control in Sub-Saharan Africa: Experience at Ampath Oncology in Western Kenya (Now Available)

      09:45 - 09:45  |  Presenter: Fredrick Chite Asirwa

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-17 - Getting to Know Our Weapons Better. Analyze from Real Life Data from León, Spain (Now Available)

      09:45 - 09:45  |  Presenter: Luis Felipe Sánchez-Cousido

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-18 - Pleural Malignant Effusion. Is it Possible to Predict Recurrence After Palliative Pleural Procedure?

      09:45 - 09:45  |  Presenter: Fernando Conrado Abrao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-19 - Understanding Physician Barriers in the Management of Lung Cancer in Nepal. Can Educational Intervention Make a Difference? (Now Available)

      09:45 - 09:45  |  Presenter: Ramila Shilpakar

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-20 - Trial in Progress: Cardiac Toxicity in Patients Undergoing Curative Intent Radiotherapy for Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Kathryn Elizabeth Banfill

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-21 - Does Age Affect What Patients Value When Considering Lung Cancer Treatments? Evidence from a National Survey

      09:45 - 09:45  |  Author(s): Carolyn J Presley

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-22 - Reduced Delays in Diagnostic Pathways for Non-Small Cell Lung Cancer After Local and National Interventions (Now Available)

      09:45 - 09:45  |  Presenter: Dan Lærum

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-23 - Comparison of Electronic and Traditional Thoracic Drainage Systems for Postoperative Chest Tube Management After Pulmonary Resection

      09:45 - 09:45  |  Presenter: Ching Feng Wu

      • Abstract

      Loading...

    • +

      P1.16-24 - Detection of Plasma T790M Mutation After the First Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer in the Real World (Now Available)

      09:45 - 09:45  |  Presenter: Haiyan Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-25 - Impact of Pirfenidone on the Risk Scoring System of Postoperative Acute Exacerbation of Interstitial Pneumonia in Lung Cancer

      09:45 - 09:45  |  Presenter: Ryohei Matsushima

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-26 - Epithelial Growth Factor Receptor Mutation Pattern in Non-Small Cell Lung Cancer of Xuanwei Region in Southwestern China (Now Available)

      09:45 - 09:45  |  Author(s): Li Lv

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-27 - Risk Factors Associated with a Second Primary Lung Cancer (SPLC) in Patients (Pts) with an Initial Primary Lung Cancer (IPLC)

      09:45 - 09:45  |  Presenter: Misako Nagasaka

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-28 - The Humanistic Burden of ALK+ NSCLC: Findings from the ALKConnect Patient Insight Network and Research Platform

      09:45 - 09:45  |  Presenter: Huamao Mark Lin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-29 - Profiling Immune-Related Adverse Events (irAEs) in Patients with Anti-PD-1 for Advanced Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Yukihiro Toi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-30 - Impact of Patient TKI Copayments on Insurance Expenditure in Advanced EGFR or ALK Positive Non-Small Cell Lung Cancer (NSCLC)

      09:45 - 09:45  |  Presenter: Bernardo Haddock Lobo Goulart

      • Abstract

      Loading...

    • +

      P1.16-31 - Body Mass Index Relating to Patient-Reported Symptoms in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Author(s): Qiuling Shi

      • Abstract

      Loading...

    • +

      P1.16-32 - Empowering Lung Cancer Survivors and Family Members to “Breathe Easier”: Adaptation and Evaluation of a M-Health Intervention (Now Available)

      09:45 - 09:45  |  Presenter: Otis LeShaun Owens

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-33 - From a Systematic Review to Real World Evidence: Integrating Gender as a Clinical Risk Factor in NSCLC 

      09:45 - 09:45  |  Author(s): Noor Asaad Alsaadoun

      • Abstract

      Loading...

    • +

      P1.16-34 - Association Between Skin Reactions and Clinical Benefit in Patients Treated with Anti-PD-1 Treatment for Advanced Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Mari Aso

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-35 - The Prognostic Impact of Sarcopenia on the Clinical Outcome of Thoracic Surgery for Non-Small Cell Lung Cancer in Elderly Patients

      09:45 - 09:45  |  Presenter: Akihiro Miura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-36 - Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting

      09:45 - 09:45  |  Presenter: Melissa Pavilack

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-37 - Correlation Between the Actual Measurement Value After Lung Lobectomy and the Predicted Value of Forced Expiratory Volume in 1 Second (Now Available)

      09:45 - 09:45  |  Presenter: Tatsuya Hayashi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-38 - Racial Disparities in Long-Term Survival After Surgical Resection in the US (Now Available)

      09:45 - 09:45  |  Presenter: Meghan Taylor

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-39 - Oncology Emergencies in Patients with Lung Cancer: Experience of One Hospital (Now Available)

      09:45 - 09:45  |  Presenter: Marta Vilaça

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-40 - Real-World Neurocognitive Function in Lung Cancer: Initial Results of the PRO-Long Study

      09:45 - 09:45  |  Presenter: Lotte Anna Van Der Weijst

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-41 - Timing, Sites, and Correlates of Lung Cancer Recurrence: The Missing Pieces in National Datasets

      09:45 - 09:45  |  Author(s): Chelsea M Karacz

      • Abstract

      Loading...

    • +

      P1.16-42 - Real-World Trends in Systemic Anticancer Therapy (SACT) for Squamous Advanced NSCLC (aNSCLC) in the US, 2011–2018

      09:45 - 09:45  |  Presenter: Vamsidhar Velcheti

      • Abstract

      Loading...

    • +

      P1.16-43 - Prevalence of Clinical and Sub-Clinical Malnutrition in Advanced Non-Small-Cell Lung Cancer Patients and Association with Outcome

      09:45 - 09:45  |  Author(s): Ilaria Trestini

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-44 - Multiple Primary Cancers (MPC) in a Cohort of Lung Cancer (LC) Patients (P): Incidence and Clinical Features

      09:45 - 09:45  |  Presenter: Carlos Erasun Lecuona

      • Abstract

      Loading...

    • +

      P1.16-45 - Changing Attitudes Regarding Lung Cancer: Shame, Embarrassment, and Hope

      09:45 - 09:45  |  Presenter: Joan H Schiller

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-46 - Genetic Testing Patterns, Treatment Characteristics, and Overall Survival in ALK-Positive Metastatic NSCLC Patients Treated with Ceritinib

      09:45 - 09:45  |  Presenter: Julien Mazieres

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-47 - Embedding Research (and Evidence) in Cancer Healthcare - EnRICH

      09:45 - 09:45  |  Presenter: Bea Brown

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.16-48 - Experiences of Pts on 1st Line Care (EP1C): Symptoms and Impacts of EGFR TKI Therapy on Real-World Daily Lives of NSCLC Pts

      09:45 - 09:45  |  Presenter: Ivy Elkins

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.17 - Treatment of Early Stage/Localized Disease

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Treatment of Early Stage/Localized Disease
    • Presentations: 17
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.17-01 - Surgical Outcome of Early Stage Lung Cancer Related vs Unrelated to Honeycomb Lesions with Interstitial Pneumonia (Now Available)

      09:45 - 09:45  |  Presenter: Makoto Fujiwara

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-02 - The Investigation of Intraoperative Marking by Transbronchial Low Power Laser Irradiation in Human Lung

      09:45 - 09:45  |  Presenter: Keishi Ohtani

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-03 - Inter-Fraction Variability of 18-FDG PET During Lung SBRT and the Effect of Systemic and Immunotherapy: Results of a Prospective Pilot Study (Now Available)

      09:45 - 09:45  |  Presenter: Sibo Tian

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-04 - Multicenter Observational Study of Node-Negative Non-Small Cell Lung Cancer Patients Who Are Excluded from a Clinical Trial

      09:45 - 09:45  |  Presenter: Hiroyuki Sakurai

      • Abstract

      Loading...

    • +

      P1.17-05 - What Is the Optimal Number of Examined Lymph Node in Stage IA Non-Small Cell Lung Cancer?

      09:45 - 09:45  |  Author(s): Liu Huang

      • Abstract

      Loading...

    • +

      P1.17-06 - Long-Term Oncological Outcome After Thoracoscopic Lobectomy for Non-Small Cell Lung Cancer Patients (Now Available)

      09:45 - 09:45  |  Presenter: Masayuki Nakao

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-07 - Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study

      09:45 - 09:45  |  Presenter: Aaron C Tan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-08 - mRNA Expression Level of Receptor Tyrosine Kinases and Non-Receptor Tyrosine Kinases as a Recurrence Risk in Resected Adenocarcinoma of the Lung

      09:45 - 09:45  |  Presenter: Masaoki Ito

      • Abstract

      Loading...

    • +

      P1.17-09 - Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Yoshinori Handa

      • Abstract

      Loading...

    • +

      P1.17-10 - Prediction of Visceral Pleural Invasion in c-N0 Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Satoru Okada

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-11 - Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early Stage Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Corbin D Jacobs

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-12 - Osteogenic and Brain Metastases After Resection of NSCLC: Implications for the Use of FDG-PET and Brain MRI in Postoperative Surveillance (Now Available)

      09:45 - 09:45  |  Presenter: Tetsuya Mizuno

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-13 - Next Generation Sequencing of the Circulating Small RNA from Serum Identifies Small RNA-Based Biomarker Panel for Stage I-II Lung Adenocarcinoma

      09:45 - 09:45  |  Presenter: Daisuke Ueda

      • Abstract

      Loading...

    • +

      P1.17-14 - Prognostic Value of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer: A Meta-Analysis (Now Available)

      09:45 - 09:45  |  Presenter: Stephanie Tuminello

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-15 - Risk, Pattern and Outcome of Brain Metastases in Completely Resected Stage I (AJCC 8th Edition) Non-Squamous Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Jianjiao Ni

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-16 - Neo-Adjuvant Targeted Therapy in Non-Small Cell Lung Cancer Patients: A 10-Year Experience in a Tertiary Medical Center

      09:45 - 09:45  |  Presenter: Hsu Ching Huang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-17 - Outcomes Following Stereotactic Body Radiotherapy (SBRT) for Biopsy-Confirmed vs. Radiologically-Diagnosed Primary Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Tze Lui Koh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-18 - Surgery Alone or Plus Adjuvant Radiotherapy for Patients with N0 Non-Small-Cell Lung Cancer >5 cm: A Population-Based Study (Now Available)

      09:45 - 09:45  |  Presenter: Junmiao Wen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-19 - Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-Small Cell Lung Cancer Patients: Feasible and How?

      09:45 - 09:45  |  Presenter: Han-Yu Deng

      • Abstract

      Loading...

    • +

      P1.17-20 - Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Lung Cancer

      09:45 - 09:45  |  Presenter: Chenlei Zhang

      • Abstract

      Loading...

    • +

      P1.17-21 - Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions:  A Systematic Review (Now Available)

      09:45 - 09:45  |  Presenter: Hanbo Chen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-22 - Do Statins Improve Outcomes After Radical Radiotherapy for Lung Cancer? An In-Depth Analysis of Over 1100 Patients (Now Available)

      09:45 - 09:45  |  Presenter: Fei Sun

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-23 - Outcome After Surgical Resection for Clinical Stage I Non-Small Cell Lung Cancer Associated with Interstitial Lung Disease (Now Available)

      09:45 - 09:45  |  Presenter: Takahisa Koizumi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-24 - Treatment of Ultracentral Lung Tumors with Hypofractionated Radiation Therapy

      09:45 - 09:45  |  Presenter: Tamara Nsouli

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-25 - Outcomes of Primary Lung Cancer SBRT in Patients with Compromised Lung Function

      09:45 - 09:45  |  Presenter: Elaine Kirby

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-26 - Delivery of Stereotactic MR-Guided Adaptive Radiation Therapy for Peripheral Lung Tumors

      09:45 - 09:45  |  Presenter: Tobias Finazzi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-27 - Stereotactic Radiotherapy for Primary Lung Tumors: The Influence of Size

      09:45 - 09:45  |  Presenter: Isabel Rodrigues

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-28 - Refusal of Surgery for Early Stage Lung Cancer: Risk Factors and Survival

      09:45 - 09:45  |  Author(s): Joseph Rapp

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-29 - 8-year Experience of Navigational Bronchoscopy for Preoperative Localization of Subcentimeter Lung Nodules in a Small Community Hospital

      09:45 - 09:45  |  Author(s): Christian Rodolfo Galvez-Padilla

      • Abstract

      Loading...

    • +

      P1.17-30 - Sex and Age-Associated Survival Following Resected Early Stage Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Amanda Jane Williams Gibson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-31 - VATS Segmentectomies Are at Least as Safe as VATS Lobectomies (Now Available)

      09:45 - 09:45  |  Presenter: Tomasz Marjanski

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-32 - The 8th Editions of the AJCC Staging System in Terms of Predicting Recurrence and Survival in Resected NSCLC Long-Term Survivors (Now Available)

      09:45 - 09:45  |  Presenter: Seung Hwan Song

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-34 - Prognostic Significance of Preoperative CT-Determined Sarcopenia and Radiodensity in Resected Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Eun Young Kim

      • Abstract

      Loading...

    • +

      P1.17-35 - Solid Predominant Subtype Is an Independent Risk Factor for Recurrence in Patients with Pathologic Stage I Adenocarcinoma

      09:45 - 09:45  |  Presenter: Kisung Park

      • Abstract

      Loading...

    • +

      P1.17-36 - Analyses of Segmental and Intrapulmonary Lymph Node Metastases of Small-Sized Peripheral Solid Predominant Non-Small Cell Lung Cancer (NSCLC)

      09:45 - 09:45  |  Presenter: Hayato Konno

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-37 - Minimally Invasive Open Surgery (MIOS) for Clinical Stage I Lung Cancer: Perioperative Outcomes in Recent 5 Years

      09:45 - 09:45  |  Presenter: Kazuo Nakagawa

      • Abstract

      Loading...

    • +

      P1.17-38 - Does Use of Epidural Anesthesia Affects Survival of Resectable NSCLC? Analysis from a Japanese Nationwide Database (Now Available)

      09:45 - 09:45  |  Presenter: Kento James Fukumoto

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-39 - Preoperative Prediction of Incomplete Resection in Non-Small Cell Lung Cancer: An Externally Validated Clinical Nomogram (Now Available)

      09:45 - 09:45  |  Presenter: Marnix Rasing

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-40 - Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment

      09:45 - 09:45  |  Presenter: Nicholas I. Simon

      • Abstract

      Loading...

    • +

      P1.17-41 - Preoperative Prognostic Nutritional Index (PNI) as a Prognostic Factor in Patients with Clinical Stage I Non-Small-Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Mitsuyoshi Matsumoto

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.17-42 - The Importance of Lymphatic and Vascular Invasion in Stage 1 Non-Small Cell Lung Cancer and Definition of a Totally Curable Tumors

      09:45 - 09:45  |  Presenter: Akif Turna

      • Abstract

      Loading...

    • +

      P1.17-43 - Sublober Resection for Adenocarcinoma in Situ Diagnosed by Intraoperative Frozen Sections

      09:45 - 09:45  |  Presenter: Toshiyuki Shima

      • Abstract

      Loading...

  • +

    P1.18 - Treatment of Locoregional Disease - NSCLC

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Treatment of Locoregional Disease - NSCLC
    • Presentations: 14
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.18-01 - RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC (Now Available)

      09:45 - 09:45  |  Presenter: Santiago Ponce Aix

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-02 - The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLC

      09:45 - 09:45  |  Presenter: John Victor Heymach

      • Abstract

      Loading...

    • +

      P1.18-03 - How to Predict High Grade Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Thoracic Radiotherapy (Now Available)

      09:45 - 09:45  |  Presenter: Jaume Bordas-Martinez

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-04 - Neoadjuvant Ceritinib for Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: SAKULA Trial

      09:45 - 09:45  |  Presenter: Yoshitaka Zenke

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-05 - ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC:  Long-Term Survival Update and Analysis of Post-Progression Therapy (Now Available)

      09:45 - 09:45  |  Presenter: Greg Durm

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-06 - Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Author(s): Ning Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-07 - Postoperative Complications and Long-Term Survival Among Octogenarians Treated Surgically for Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Masanori Shimomura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-08 - Survival Outcomes of Salvage Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Sara Mieko Moore

      • Abstract

      Loading...

    • +

      P1.18-09 - Trimodal Treatment of Locally Advanced Non-Small Cell Lung Cancer: Model-Based Comparison with Chemoradiation Only  (Now Available)

      09:45 - 09:45  |  Presenter: Malene Strange

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-10 - The Prognostic Impact of the Extent of Nodal Involvement in NSCLC Treated with Radical Chemoradiation

      09:45 - 09:45  |  Presenter: Connie Yip

      • Abstract

      Loading...

    • +

      P1.18-11 - Dose Dense Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable/Borderline Resectable NSCLC - A Phase II Trial  (Now Available)

      09:45 - 09:45  |  Presenter: Abhenil Mittal

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-12 - PACIFIC-4/RTOG 3515: Phase III Study of Durvalumab Following SBRT for Unresected Stage I/II, Lymph-Node Negative NSCLC

      09:45 - 09:45  |  Author(s): Clifford Robinson

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-13 - Predicting Failure Patterns in Patients with Inoperable Local Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy (Now Available)

      09:45 - 09:45  |  Presenter: Xueru Zhu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-14 - The Prognostic Significance of Significant Weight Loss in Stage III NSCLC Undergoing Definitive CRT After FDG-PET Staging (Now Available)

      09:45 - 09:45  |  Presenter: Clare Senko

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-15 - Dosimetric and Toxicity Benefits of Adaptive IMRT in Patients with Stage III Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Yinnan Meng

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-16 - Is Tumor Shrinking During Chemoradiation for LA-NSCLC a Biomarker for Outcome? (Now Available)

      09:45 - 09:45  |  Presenter: Sara Ramella

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-17 - Survival After Adjuvant Chemotherapy in Completely Resected N1 Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Emily Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-18 - Feasibility of Hypofractionated Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Noelle Caroline Van Der Voort Van Zyp

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-19 - Invasive Mediastinal Staging Is Mandatory for Upfront Surgery for N2 Disease (Now Available)

      09:45 - 09:45  |  Presenter: Andrew Selvaraj

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-20 - The Relationship Between the Recurrence Timing and Inflammation-Based Prognostic Scores in Resected Non-Small-Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Daisuke Noma

      • Abstract

      Loading...

    • +

      P1.18-21 - Short and Mid-Term Outcomes of Multimodal Treatment for Locally-Advanced Non Small Cell Lung Cancer in Elderly Patients

      09:45 - 09:45  |  Author(s): stefano Bongiolatti

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-22 - Impact of Using Volumetric Modulated Arc Therapy on Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer

      09:45 - 09:45  |  Presenter: Nobuki Imano

      • Abstract

      Loading...

    • +

      P1.18-23 - Use of Perfusion SPECT to Preserve Functional Lung in Radiotherapy for Non-Small-Cell Lung Cancer (NSCLC) Patients (Now Available)

      09:45 - 09:45  |  Presenter: Sara Ramella

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-24 - Neoadjuvant Therapy versus Upfront Surgery for NSCLC Patients with Clinically Suspected Subaortic or Paraaortic Lymph Nodes

      09:45 - 09:45  |  Presenter: Junghee Lee

      • Abstract

      Loading...

    • +

      P1.18-25 - The Impact of Radiation Pneumonitis on Prognosis of Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy (Now Available)

      09:45 - 09:45  |  Presenter: Takahiro Akita

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-26 - Pretreatment Risk Factors for Postoperative Pulmonary Complication After Neoadjuvant Concurrent Chemoradiotherapy for NSCLC

      09:45 - 09:45  |  Presenter: Woo Sik Yu

      • Abstract

      Loading...

    • +

      P1.18-27 - Chemoradiotherapy of Inoperable Non-Small Cell Lung Cancer (NSCLC) with IGRT Technique Using TomoTherapy HD

      09:45 - 09:45  |  Presenter: Milada Zemanova

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.18-28 - Salvage Surgery for Residual Lesion/Local Reprogression After Initial Medical Treatment in Advanced Non-Small Cell Lung Cancer (Now Available)

      09:45 - 09:45  |  Presenter: Keita Nakanishi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PR02 - Press Conference

    • Type: Press Conference
    • Track: Immuno-oncology
    • Presentations: 4
    • Now Available
    • Coordinates: 9/08/2019, 09:45 - 10:30, CC7.1 A&B
    • +

      PR02.01 - Summary of Day's Plenary

      09:45 - 09:50  |  Presenter: Enriqueta Felip

      • Abstract

      No abstract available for this presentation

    • +

      PR02.02 - Phase 1 Study of Safety, Tolerability, P­­K and Efficacy of AMG 510, a Novel KRAS G12C Inhibitor, Evaluated in NSCLC (Now Available)

      09:50 - 09:57  |  Presenter: Ramaswamy Govindan

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR02.03 - Announcement of JTO Clinical and Research Reports

      09:57 - 10:02  |  Presenter: Alex A Adjei

      • Abstract

      No abstract available for this presentation

    • +

      PR02.04 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial (Now Available)

      10:02 - 10:09  |  Presenter: Naiyer A Rizvi

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR02.05 - CheckMate 817: First-Line Nivolumab + Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC (Now Available)

      10:09 - 10:16  |  Presenter: Fabrice Barlesi

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR02.06 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC

      10:16 - 10:23  |  Presenter: Corey Jay Langer

      • Abstract

      No abstract available for this presentation

    • +

      PR02.07 - Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC (Now Available)

      10:23 - 10:30  |  Presenter: Marina Chiara Garassino

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ES01 - What Is the Role of Chemotherapy in the Era of Immunotherapy in Advanced NSCLC?

    • Type: Educational Session
    • Track: Advanced NSCLC
    • Presentations: 6
    • Now Available
  • +

    ES02 - Management of Oncogene Addicted Patients with Stage III NSCLC

    • Type: Educational Session
    • Track: Treatment of Locoregional Disease - NSCLC
    • Presentations: 5
    • Now Available
    • Moderators:Carlos Camps
    • Coordinates: 9/08/2019, 10:30 - 12:00, Vancouver (2003)
  • +

    ES03 - BAP-1 and Other Novel Molecular and Metabolic Targets in Mesothelioma

    • Type: Educational Session
    • Track: Mesothelioma
    • Presentations: 6
    • Now Available
    • Moderators:Michele Carbone
    • Coordinates: 9/08/2019, 10:30 - 12:00, Tokyo (1982)